Bat Bite Vaccine

AIM Honor is a Bat Bite Vaccine supplier from China. Our vaccines have stable potency and are easy to store, effectively addressing the unique risks associated with bat bites.

Bats are important hosts of the rabies virus. Bat bites often result in small, inconspicuous wounds that are easily overlooked. The virus is highly virulent, has a short incubation period, and can also cause indirect exposure through saliva contamination of mucous membranes, making prevention and control extremely challenging.  Related immunization should follow the core principles of prevention even without visible wounds, combined use of immunoglobulin, and complete and standardized vaccination.

Special Risks of Bat Bites

Bats are important hosts of the rabies virus. Their bite wounds are small and concealed, which are easy to be ignored. In addition, the rabies virus strains carried by bats are more virulent and have a shorter incubation period. Once the disease develops, the fatality rate is nearly 100%. Besides, bats may also cause indirect exposure through saliva contaminating mucous membranes, making prevention and control extremely difficult.

Core Principles of Immunization for Bat Bites

Prevention is Required Even Without Wounds: Even if no obvious wound is found, prevention procedures must be initiated only with close contact with bats.

Combination with Rabies Immunoglobulin: For Category III exposure, rabies immunoglobulin must be injected together with vaccine vaccination.

Standardized Full-course Vaccination: The full course of immunization must be completed, and shall not be interrupted due to wound healing.

AIM Honor Vaccine: A Professional Protection Solution for Bat Bites

AIM's Conventional Vero Cell Rabies Vaccine and Serum-free Vero Cell Rabies Vaccine can effectively deal with the risk of bat bites:

Broad-spectrum Protection Adapted to Bat StrainsThe aG strain and PV-2061 strain used in the vaccines have high homology in G protein with bat-derived rabies virus strains. The neutralizing antibodies produced after vaccination can effectively neutralize the virus carried by bats, with a 100% antibody seroconversion rate 14 days after vaccination, building a protective barrier for people exposed to bats.

Emergency Adaptation to Concealed Exposure ScenariosThe product supports emergency vaccination within 24 hours after exposure. The serum-free vaccine is also suitable for people exposed to bats with high allergy risk. In addition, the vaccine has stable potency, with a validity period of 36 months when stored at 2-8℃ in the dark, which is convenient for CDC institutions and medical institutions to stock up, meeting the emergency prevention and control needs of sudden bat exposure.